Prevention of propofol injection pain: Comparison between lidocaine and ramosetron

Background: Propofol causes a high incidence of pain during intravenous (IV) injection. The aim of this randomized, placebo-controlled, double-blinded study was to determine whether pre-treatment with IV ramosetron, used for prophylaxis of postoperative nausea and vomiting (PONV), would reduce propo...

Full description

Saved in:
Bibliographic Details
Main Authors: Dipali Singh (Author), Sathyanarayan Jagannath (Author), Shio Priye (Author), Shivaprakash (Author), Chandrashekar Kadli (Author), Durgaprasad Reddy (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2014-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1f3c8fa9483d4901b6a1390c361275c4
042 |a dc 
100 1 0 |a Dipali Singh  |e author 
700 1 0 |a Sathyanarayan Jagannath  |e author 
700 1 0 |a Shio Priye  |e author 
700 1 0 |a Shivaprakash  |e author 
700 1 0 |a Chandrashekar Kadli  |e author 
700 1 0 |a Durgaprasad Reddy  |e author 
245 0 0 |a Prevention of propofol injection pain: Comparison between lidocaine and ramosetron 
260 |b Wolters Kluwer Medknow Publications,   |c 2014-01-01T00:00:00Z. 
500 |a 0970-9185 
500 |a 10.4103/0970-9185.130023 
520 |a Background: Propofol causes a high incidence of pain during intravenous (IV) injection. The aim of this randomized, placebo-controlled, double-blinded study was to determine whether pre-treatment with IV ramosetron, used for prophylaxis of postoperative nausea and vomiting (PONV), would reduce propofol-induced pain as an equivalent to lidocaine. Materials and Methods: Hundred and twenty American Society of Anesthesiologists grade (ASA) I and II patients were randomly assigned into three groups (40 in each). Group N received 2 ml of 0.9% saline, Group L received 2 ml of lidocaine, and Group R received 2 ml of ramosetron. Mid forearm was occluded manually before injection and released after 1 min and then propofol was injected over 5 s. Patients were observed and questioned 15 s later if they had pain in the arm and pain was scored on a four-point scale: 0 = no pain, 1 = mild pain, 2 = moderate pain, and 3 = severe pain. Unpaired Student's t-test and chi-square test/Fisher' exact test were used to analyze results. Results: The incidence of pain in groups N, L, and R were 65, 35, and 30%, respectively. Pain was reduced significantly in the groups L and R (P < 0.05). Two patients each in Groups L and R (5% each) had moderate and severe pain. This difference in pain was statistically insignificant, but when compared to Group N (25 and 30%, respectively) it was statistically significant. Conclusion: Pretreatment with ramosetron 0.3 mg and lidocaine 40 mg are equally effective in preventing pain from propofol injection. 
546 |a EN 
690 |a Injection 
690 |a lidocaine 
690 |a pain 
690 |a propofol 
690 |a ramosetron 
690 |a Anesthesiology 
690 |a RD78.3-87.3 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Anaesthesiology Clinical Pharmacology, Vol 30, Iss 2, Pp 213-216 (2014) 
787 0 |n http://www.joacp.org/article.asp?issn=0970-9185;year=2014;volume=30;issue=2;spage=213;epage=216;aulast=Singh 
787 0 |n https://doaj.org/toc/0970-9185 
856 4 1 |u https://doaj.org/article/1f3c8fa9483d4901b6a1390c361275c4  |z Connect to this object online.